Medtronic: Medtronic sensor receives FDA clearance

GALWAY, Ireland - Medtronic has received clearance from the U.S. Food and Drug Administration for the Simplera Sync sensor for use with the MiniMed 780G system. With this approval, the MiniMed 780G system now offers more flexibility for users of the company's most advanced insulin delivery system featuring Meal Detection technology with both the Guardian 4 sensor and Simplera Sync sensor. The Simplera Sync is a disposable, all-in-one sensor that requires no fingersticks with SmartGuard or overtape and features a simple, two-step insertion process. "We're committed to driving innovation that makes life easier for those living with diabetes so they can forget about their diabetes as much as possible throughout the day," said Que Dallara, EVP and president of Medtronic Diabetes. "Our MiniMed 780G system delivers advanced diabetes technology for so many around the world, and we're excited to continue evolving this experience with expanded CGM options -including our Simplera Sync sensor, which we look forward to bringing to people living with diabetes in the U.S." A limited launch of the Simplera Sync sensor will begin in the U.S. in the fall of 2025.